Research and Markets has announced the addition of the "Infusion Pumps - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, ...

DUBLIN--(BUSINESS WIRE)--The "Global Infusion Pumps Market (2023 Edition): Analysis By Product Type (Volumetric, Ambulatory, Insulin, PCA, Syringe Pumps, Others), By Indication, End Use, By Region, By ...

The rapid development of pharmaceuticals and prescribed combinations has made administering intravenous drug therapy more involved than ever before, leading to a new generation of “smart pumps” ...

Cardinal Health’s CAH Monoject syringes get unfavorable FDA recommendation following reports of delay in therapy as well as inaccurate therapy (overdose or underdose) when used with a syringe pump or ...

Dublin, May 27, 2021 (GLOBE NEWSWIRE) -- The "Global Patient-Controlled Analgesic Pumps Market By Type, By Application, By End-use, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - ...

Bryanne Patail, biomedical engineer at the U.S. Department of Veterans Affairs, National Center for Patient Safety, discusses patient-controlled analgesia (PCA) pumps and what the Veterans Health ...

The Food and Drug Administration voiced concerns in a Monday letter that Cardinal Health failed to sufficiently mitigate the risk of incompatibility between its syringes and certain pumps in its ...

Use sedating medications, such as hypnotics or sedatives. Patients in these categories may require another form of pain management or careful monitoring for respiratory effects. All PCA pumps should ...

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...

The FDA has alerted healthcare providers not to use Cardinal Health (NYSE:CAH) Monoject syringes with syringe pumps and patient-controlled analgesia, or PCA, pumps until it further evaluates reports ...